Federal Register / Vol. 65, No. 76 / Wednesday, April 19, 2000 / Notices 20999

ESTIMATES OF ANNUALIZED HOUR BURDEN

Subjects Number of

respondents

Responses

per

respondent

Total

responses

Hrs. per

response

Total hour

burden

Organ Procurement Organizations ...................................... 60 1 60 .33 20

Send comments to Susan G. Queen,

Ph.D., HRSA Reports Clearance Officer,

Room 14–33, Parklawn Building, 5600

Fishers Lane, Rockville, MD 20857.

Written comments should be received

within 60 days of this notice.

Dated: April 13, 2000.

Jane Harrison,

Director, Division of Policy Review and

Coordination.

[FR Doc. 00–9757 Filed 4–18–00; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

Periodically, the Health Resources

and Services Administration (HRSA)

publishes abstracts of information

collection requests under review by the

Office of Management and Budget, in

compliance with the Paperwork

Reduction Act of 1995 (44 U.S.C.

Chapter 35). To request a copy of the

clearance requests submitted to OMB for

review, call the HRSA Reports

Clearance Office on (301)-443–1129.

The following request has been

submitted to the Office of Management

and Budget for review under the

Paperwork Reduction Act of 1995:

Proposed Project: Grants for Hospital

Construction and Modernization—

Federal Right of Recovery and Waiver

of Recovery (42 CFR, Subpart H) (OMB

No. 0915–0099)—Extension

The regulation known as ‘‘Federal

Right of Recovery and Waiver of

Recovery,’’ provides a means for the

Federal Government to recover grant

funds and a method of calculating

interest when a grant-assisted facility

under Titles VI and XVI is sold or

leased, or there is a change in use of the

facility. It also allows for a waiver of the

right of recovery under certain

circumstances. Facilities are required to

provide written notice to the Federal

Government when such a change

occurs; and to provide copies of sales

contracts, lease agreements, estimates of

current assets and liabilities, value of

equipment, expected value of land on

the new owner’s books and remaining

depreciation for all fixed assets involved

in the transactions, and other

information and documents pertinent to

the change of status.

ESTIMATES OF ANNUALIZED HOUR BURDEN

Regulation Number of

respondents

Responses

per

respondent

Hours per

response

Total burden

hours

124.704(b) and 707 ......................................................................................... 20 1 3 60

Written comments and

recommendations concerning the

proposed information collection should

be sent within 30 days of this notice to:

Wendy A. Taylor, Human Resources

and Housing Branch, Office of

Management and Budget, New

Executive Office Building, Room 10235,

Washington, DC 20503.

Dated: April 13, 2000.

Jane Harrison,

Director, Division of Policy Review and

Coordination.

[FR Doc. 00–9756 Filed 4–18–00; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel, Early

Therapeutics Development with Phase 2

Emphasis.

Date: May 8–9, 2000.

Time: 8 am to 5 pm.

Agenda: To review and evaluate contract

proposals.

Place: Ramada Inn Rockville, 1775

Rockville Pike, Rockville, MD 20852.

Contact Person: Lalita D. Palekar, Scientific

Review Administrator, Special Review,

Referral and Resources Branch, Division of

Extramural Activities, National Cancer

Institute, National Institutes of Health, 6116

Executive Boulevard, Room 8066, Bethesda,

MD 20892–7405, 301–496–7575.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

21000 Federal Register / Vol. 65, No. 76 / Wednesday, April 19, 2000 / Notices

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: April 11, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–9720 Filed 4–18–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Human Genome Research

Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Committee Act, as amended (5

U.S.C. Appendix 2), notice is hereby

given of the following meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Human

Genome Research Institute Special Emphasis

Panel.

Date: April 27, 2000.

Time: 2 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Conference Room B2B32/Bldg 31, 31

Center Drive, Bethesda, MD 20892,

(Telephone Conference Call).

Contact Person: Ken D Nakamura,

Scientific Review Administrator, Office of

Scientific Review, National Human Genome

Research Institute, National Institute of

Health, Bethesda, MD 20892, 301–402–0838.

This notice is being published less that 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.172, Human Genome

Research, National Institutes of Health, HHS)

Dated: April 11, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–9722 Filed 4–18–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Alcohol Abuse

and Alcoholism; Notice of Closed

Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Alcohol Abuse and Alcoholism Initial

Review Group, Health Services Research

Review Subcommittee.

Date: June 15, 2000.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, Bethesda, MD 20814.

Contact Person: Elsie Taylor, Scientific

Review Administrator, Extramural Project

Review Branch, National Institute on Alcohol

Abuse and Alcoholism, National Institutes of

Health, Suite 409, 6000 Executive Blvd.,

Bethesda, MD 20892–7003, 301–443–9787,

etaylor@niaaa.nih.gov.

Name of Committee: National Institute on

Alcohol Abuse and Alcoholism Initial

Review Group, Clinical and Treatment

Subcommittee.

Date: June 29–30, 2000.

Time: 1 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 1450 Glenarm Place,

Denver, CO 80202.

Contact Person: Elsie Taylor, Scientific

Review Administrator, Extramural Project

Review Branch, National Institute on Alcohol

Abuse and Alcoholism, National Institutes of

Health, Suite 409, 6000 Executive Blvd.,

Bethesda, MD 20892–7003, 301–443–9787,

etaylor@niaaa.gov.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.271, Alcohol Research

Career Development Awards for Scientists

and Clinicians; 93.272, Alcohol National

Research Service Awards for Research

Training; 93.273, Alcohol Research Programs;

93.891, Alcohol Research Center Grants,

National Institutes of Health, HHS)

Dated: April 12, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–9715 Filed 4–18–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Allergy and Infectious Diseases Special

Emphasis Panel.

Date: May 9, 2000.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: One Washington Circle Hotel,

Presidential Board Room, One Washington

Circle, NW., Washington, DC 20037.

Contact Person: Paula S. Strickland,

Scientific Review Administrator, Scientific

Review Program, Division of Extramural

Activities, NIAID, NIH, Solar Building, Room

4C02, 6003 Executive Boulevard MSC 7610,

Bethesda, MD 20892–7610, 301–402–0643.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.855, Allergy, Immunology,

and Transplantation Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health, HHS)

Dated: April 12, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–9716 Filed 4–18–00; 8:45 am]

BILLING CODE 4140–01–M